Johnson Gordon K 4
4 · KEMPHARM, INC · Filed Nov 27, 2019
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Johnson Gordon K
COO & CFO
Transactions
- Award
Stock Option (right to buy)
2019-11-25+36,000→ 36,000 totalExercise: $0.52Exp: 2029-11-24→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 100% of the shares underlying the option will vest upon the acceptance of a new drug application for the Company's product candidate, KP415, by the U.S. Food and Drug Administration, provided that at the relevant vesting date such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.